These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 32860706)

  • 1. Patterns of Neonatal Co-Exposure to Gabapentin and Commonly Abused Drugs Observed in Umbilical Cord Tissue.
    Okoye NC; McMillin GA
    J Anal Toxicol; 2021 May; 45(5):506-512. PubMed ID: 32860706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Positivity Findings from a Universal Umbilical Cord Tissue Drug Analysis Program in Appalachia.
    Yossuck P; Tacker DH
    J Appl Lab Med; 2021 Jan; 6(1):285-297. PubMed ID: 33324976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry.
    Marin SJ; Metcalf A; Krasowski MD; Linert BS; Clark CJ; Strathmann FG; McMillin GA
    Ther Drug Monit; 2014 Feb; 36(1):119-24. PubMed ID: 24061447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
    Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
    Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords.
    Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S
    Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry.
    Ristimaa J; Gergov M; Pelander A; Halmesmäki E; Ojanperä I
    Anal Bioanal Chem; 2010 Sep; 398(2):925-35. PubMed ID: 20617307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah.
    Smid MC; Allshouse AA; McMillin GA; Nunez K; Cavin T; Worden J; Buchi K; Muniyappa B; Varner MW; Cochran G; Metz TD
    Obstet Gynecol; 2022 Aug; 140(2):153-162. PubMed ID: 35852263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.
    Montgomery DP; Plate CA; Jones M; Jones J; Rios R; Lambert DK; Schumtz N; Wiedmeier SE; Burnett J; Ail S; Brandel D; Maichuck G; Durham CA; Henry E; Christensen RD
    J Perinatol; 2008 Nov; 28(11):750-3. PubMed ID: 18596707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes.
    Concheiro M; Jones HE; Johnson RE; Choo R; Shakleya DM; Huestis MA
    J Anal Toxicol; 2010 Oct; 34(8):498-505. PubMed ID: 21819795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of opioids in umbilical cord lysates: an antibody-based rapid screening approach.
    Knight SJ; Smith AD; Wright TE; Collier AC
    Toxicol Mech Methods; 2019 Jan; 29(1):35-42. PubMed ID: 30064290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters.
    Pandya V; Wilker C; McMillin GA
    J Anal Toxicol; 2023 Feb; 47(1):96-105. PubMed ID: 35707888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
    Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
    BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma.
    Kyle AR; Carmical J; Shah D; Pryor J; Brown S
    Biomed Chromatogr; 2015 Oct; 29(10):1567-74. PubMed ID: 25808363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure.
    Colby JM
    Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
    Carlier J; La Maida N; Di Trana A; Huestis MA; Pichini S; Busardò FP
    Ther Drug Monit; 2020 Apr; 42(2):205-221. PubMed ID: 31809406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine Comprehensive Drug Screen, Low Birth Weight and Withdrawal Symptoms in a Neonatal Unit: A Case Control Study.
    Hon KL; Chan MH; Ng MH; Ho CC; Tsang KY; Tam WH; Ho CS
    Curr Clin Pharmacol; 2016; 11(4):274-281. PubMed ID: 27748174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.